You have read all your free articles, to continue reading subscribe to read the rest of this content.
Ultimovacs has announced positive results from the first cohort of 20 patients in its ongoing US-based Phase I clinical trial evaluating the company’s lead candidate, UV1, in combination with PD-1 checkpoint inhibitor, pembrolizumab, as a first line treatment in patients with metastatic malignant Already a subscriber Login You have read…
Results from a multicenter study evaluating the effects of the investigational compound brexpiprazole as monotherapy in adult patients with schizophrenia recently were published online by the American Journal of Psychiatry. Brexpiprazole is an investigational psychotropic compound discovered by Already a subscriber Login You have read all your free articles, to…
Immunicum announces that the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) in France has approved the company's Clinical Trial Application (CTA) for INTUVAX. The CTA approval enables Immunicum to include patients in France in its ongoing Phase II study - MERECA (MAlready a subscriber Login…
Biogen Idec and Sobi announce positive top-line efficacy and safety results from a phase-3 paediatric study of investigational therapy Eloctate for haemophilia A. 4713Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…
